Effect of highly active antiretroviral therapy on Tunisian aids profile: A study of 139 cases;Impact de la trithérapie anti-retrovirale sur le profil evolutif du sideen Tunisien: Etude de 139 cas

Tunisie Medicale

Volumn 81, Issue 12, 2003, Pages 956-962

  Zouiten, Fayçal ^a   Ammari, Lamia ^a   Goubantini, Ahmed ^a   Tiouiri, Hanène ^a   Slim, Amine ^b   Maamouri, Ahmed ^c   Kilani, Badreddine ^a   Kanoun, Fakher ^a   Marrakchi, Chekib ^a   Neifer, Nahed ^a   Mihoub, Leila ^d   Jenhani, Faouzi ^e   Garbouj, Mounira ^c   Ben Chaabane, Taoufik ^a  

^a LA RABTA HOSPITAL   (Tunisia)

^b CHARLES NICOLLE HOSPITAL   (Tunisia)

^c Dir des soins et de Sante de Base   (Tunisia)

^d Ministere de la Sante Publique   (France)

^e INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

Author keywords

AIDS; CD4 cell counts; HAART; HIV; Opportunistic infections; Side effects; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; DIDANOSINE; EFAVIRENZ; INDINAVIR; ISONIAZID; LAMIVUDINE; NELFINAVIR; RIFAMPICIN; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; AIDS RELATED COMPLEX; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLOOD TOXICITY; CHILD; DISEASE COURSE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERAMYLASEMIA; HYPERLIPIDEMIA; INCIDENCE; INFANT; LIPODYSTROPHY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEGALOCYTOSIS; MORTALITY; NEUTROPENIA; OPPORTUNISTIC INFECTION; RETROSPECTIVE STUDY; SKIN MANIFESTATION; THROMBOCYTOPENIA; TOXOPLASMOSIS; TUNISIA; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CHILD; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TUNISIA; VIRAL LOAD;

EID: 10744228244     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Rapport 2002 Sous la direction du Professeur JF Delfraissy. Prise en charge des personnes infectées par le VIH. Médecine Sciences Flammarion 2002: 35-46; 47-62; 117-136; 163-206.
2. Laurent fonquernie, Pierre-Marie Girard. Classification, définitions et facteurs prévisionnels de l'évolution de l'infection VIH-1 chez l'adulte. In P M Girard, Ch Katlama, G.Pialoux. VIH Editon 2001: 35-48
3. Anne Laporte, Florence Lot. Epidémiologie: situation actuelle et tendances. In P M Girard, Ch Katlama, G.Pialoux. VIH Editon Maloine 2001: 49-59.
4. F.Zouiten, A.Ben Said, L.Ammari, A.Slim, F.Kanoun, T.Ben Chaabane Le Sida chez la femme tunisienne. Etude de 96 cas La Tunisie Médicale, 2002, 80, 7, 402-406
5. Ben Rachid MS, Khaled S, Tiouiri H, Beiaoui M, Besbes M, Gastli M, Kallel K, Chaker E, F.Zouiten, Lakhoua R. A.Zribi Pneumocystose Pulmonaire en Tunisie. A propos de 6 cas La Tunisie Médicale 1994, 72, 446-49.
6. Le Moing V, Chene G, Carrieri MP, et al. Predictors of virological rebound in HIV-1 infected patients initiating a protease inhibitor-containing regimen AIDS 2002, 16: 21-29
7. Organisation Mondiale de la Santé. Recommandations pour une approche de santé unique. Améliorer l'accès aux traitements anti-rétroviraux dans les pays à ressources limitées. Avril 2002: 16-20
8. Phillips AN, Staszewski S, Weber R et al. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA 2001,286:2560-2567.
9. Christiane Schieferstein. Management of Side Effects. In Hoffmann Kamps HIV Medicine 2003 Flying Publisher 2003: 239-254.
10. Christine Kaltama, Gilles Pialoux, Pierre Marie Girard. Traitement Antirétroviraux. In P M Girard, Ch Katlama, G.Pialoux. VIH Editon Maloine 2001: 301-328
11. Motasim Badri, Douglas Wilson, Robin Wood. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. The Lancet 2002, 359: 2059-64
12. Juan C, Lopez Bernardo De Quiros, José M Miro, José P. Pena et al. A randomized trial of the discontinuation of primary and secondary prophylaxis against pneumocystis carinii pneunomonia after highly active antiretroviral therapy in patients with HIV infection. The New England Journa of Medicine, 2001, 344: 159-67
13. Frank J. Palella, Kathleen M Delaney, Anne C Moorman et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. The New England Journa of Medicine, 1998,338:863-60